DNA Synthesis Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	183 Pages	Fortune Business Insights Pvt. Ltd.	September, 2024	FOB19185779

Best Price Guarantee
Price	from $4,850
Length	183 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	September, 2024
SKU	FOB19185779

DNA Synthesis Market

Growth Factors of DNA Synthesis Market

The DNA Synthesis Market size was valued at USD 4.04 billion in 2023, and the market is now projected to grow fromUSD 4.56 billion in 2024 to USD 16.08 billion by 2032, exhibiting a CAGR of 17.1% during the forecast period of 2024-2032.

The COVID-19 pandemic substantially impacted the DNA synthesis marketplace, initially causing disruptions in deliver chains and delaying research activities. However, the heightened call for for diagnostic attempting out and vaccine development at some point of the pandemic spurred boom inside the marketplace. Companies focused on artificial biology and DNA synthesis technology saw increased investments and collaborations to accelerate the producing of COVID-19 related studies and therapeutics. The pandemic underscored the importance of speedy DNA synthesis for developing vaccines and diagnostics, in the long run driving innovation and expanding the market's scope in healthcare and biotechnology.

A key fashion inside the DNA synthesis marketplace is the developing adoption of automation and AI-pushed generation. These advancements are permitting quicker, extra accurate, and fee-powerful synthesis strategies. Companies are an increasing number of integrating AI algorithms to optimize sequence format, are anticipating synthesis achievement prices, and reduce mistakes. Automation is streamlining workflows, from gene synthesis to assembly and checking out, that is essential for scaling up production in artificial biology and customized remedy. This fashion is using innovation, reducing time-to-marketplace for present day products, and expanding the applications of DNA synthesis in fields like drug improvement, agriculture, and commercial biotechnology.

The DNA synthesis marketplace is being pushed with the resource of numerous key factors, consisting of the developing call for for personalized medication and upgrades in genomic research. Innovations in synthetic biology and genomics are fueling the development of custom designed remedies and diagnostic equipment. The upward thrust of subsequent-technology sequencing era and growing applications in drug discovery and agricultural biotechnology additionally make contributions to market growth. Additionally, declining prices of DNA synthesis and extended investment in research and development similarly bolster the market. As researchers and clinicians are in search of for extra unique and green genetic solutions, the DNA synthesis marketplace continues to increase.

Comprehensive Analysis of DNA Synthesis Market

The DNA Synthesis market growth is rising at an exponential rate due to its marketplace segmentation. This market expansion correctly affords a detailed local assessments thinking about the dominant supply and call for forces that effect the enterprise. These segmentations are methodically segregated by By Product & Service, By Type, By Application, By End-user .By Product & Service include Products ,Services. By Type include Oligonucleotide Synthesis, Gene Synthesis. By Application include Diagnostics ,Therapeutics , Research & Development. By End-user Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) & Contract Development and Manufacturing Organizations (CDMOs), Others.

The North America region lead the DNA Synthesis market share by benefitting a market size of USD 2.25 billion due to demand for products used in machinery, equipment, control systems, and power distribution networks, contributing to market expansion .

The top players in the market play a crucial role in the industry assuring market growth and setting market standards. These players include, Google LLC (Alphabet, Inc.), Magic Leap, Inc., ReWalk Robotics, SAMSUNG, B-Temia, Panasonic Holdings Corporation, NVIDIA Corporation, Microsoft, Ekso Bionics, Vuzix,these market players provide a level-playing competitive landscape.

November 2023: Twist Bioscience introduced Twist Express Genes, a modern gene synthesis service offering genes ranging from zero.3 to five.0kb with an expedited transport turnaround of 5 to seven business employer days.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Unit Value (USD billion)

Growth Rate CAGR of 17.1% from 2024-2032

Segmentation By Product & Service

- Products

- Instruments

- Reagents & Consumables

Services

By Type

- Oligonucleotide Synthesis

- Gene Synthesis

By Application

- Diagnostics

- Infectious Diseases

- Cancer

- Others

Therapeutics

- Gene Therapy

- Preventive Medicine

- Others

Research & Development

- Cloning and Gene Editing

- Drug Discovery & Development

- Others

By End-user

- Pharmaceutical & Biotechnology Companies

- Contract Research Organizations (CROs) & Contract Development and Manufacturing Organizations (CDMOs)

- Others

By Region

- North America (By Product & Service, By Type, By Application, By End-user, and By Country)

- U.S.

- Canada

Europe (By Product & Service, By Type, By Application, By End-user, and By Country/Sub-Region)

- U.K.

- Germany

- France

- Spain

- Italy

- Scandinavia

- Rest of Europe

Asia Pacific (By Product & Service, By Type, By Application, By End-user, and By Country/Sub-Region)

- Japan

- China

- India

- Australia

- Southeast Asia

- Rest of Asia Pacific

Latin America (By Product & Service, By Type, By Application, By End-user, and By Country/Sub-Region)

- Brazil

- Mexico

- Rest of Latin America

Middle East & Africa (By Product & Service, By Type, By Application, By End-user, and By Country/Sub-Region)

- GCC

- South Africa

- Rest of Middle East & Africa

Please Note: It will take 5-6 business days to complete the report upon order confirmation.

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Technological Developments in the DNA Synthesis; 4.2. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.; 4.3. New Product Launches; 4.4. Impact of COVID-19 on the DNA Synthesis Market
5. Global DNA Synthesis Market Analysis, Insights and Forecast, 2019-2032: 5.1. Market Analysis, Insights and Forecast – By Product & Service; 5.1.1. Products; 5.1.1.1. Instruments; 5.1.1.2. Reagents & Consumables; 5.1.2. Services; 5.2. Market Analysis, Insights and Forecast – By Type; 5.2.1. Oligonucleotide Synthesis; 5.2.2. Gene Synthesis; 5.3. Market Analysis, Insights and Forecast – By Application; 5.3.1. Diagnostics; 5.3.1.1. Infectious Diseases; 5.3.1.2. Cancer; 5.3.1.3. Others; 5.3.2. Therapeutics; 5.3.2.1. Gene Therapy; 5.3.2.2. Preventive Medicine; 5.3.2.3. Others; 5.3.3. Research & Development; 5.3.3.1. Cloning and Gene Editing; 5.3.3.2. Drug Discovery & Development; 5.3.3.3. Others; 5.4. Market Analysis, Insights and Forecast – By End User; 5.4.1. Pharmaceutical & Biotechnology Companies; 5.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs); 5.4.3. Others; 5.5. Market Analysis, Insights and Forecast – By Region; 5.5.1. North America; 5.5.2. Europe; 5.5.3. Asia Pacific; 5.5.4. Latin America; 5.5.5. Middle East & Africa
6. North America DNA Synthesis Market Analysis, Insights and Forecast, 2019-2032: 6.1. Market Analysis, Insights and Forecast – By Product & Service; 6.1.1. Products; 6.1.1.1. Instruments; 6.1.1.2. Reagents & Consumables; 6.1.2. Services; 6.2. Market Analysis, Insights and Forecast – By Type; 6.2.1. Oligonucleotide Synthesis; 6.2.2. Gene Synthesis; 6.3. Market Analysis, Insights and Forecast – By Application; 6.3.1. Diagnostics; 6.3.1.1. Infectious Diseases; 6.3.1.2. Cancer; 6.3.1.3. Others; 6.3.2. Therapeutics; 6.3.2.1. Gene Therapy; 6.3.2.2. Preventive Medicine; 6.3.2.3. Others; 6.3.3. Research & Development; 6.3.3.1. Cloning and Gene Editing; 6.3.3.2. Drug Discovery & Development; 6.3.3.3. Others; 6.4. Market Analysis, Insights and Forecast – By End User; 6.4.1. Pharmaceutical & Biotechnology Companies; 6.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs); 6.4.3. Others; 6.5. Market Analysis, Insights and Forecast – By Country; 6.5.1. U.S.; 6.5.2. Canada
7. Europe DNA Synthesis Market Analysis, Insights and Forecast, 2019-2032: 7.1. Market Analysis, Insights and Forecast – By Product & Service; 7.1.1. Products; 7.1.1.1. Instruments; 7.1.1.2. Reagents & Consumables; 7.1.2. Services; 7.2. Market Analysis, Insights and Forecast – By Type; 7.2.1. Oligonucleotide Synthesis; 7.2.2. Gene Synthesis; 7.3. Market Analysis, Insights and Forecast – By Application; 7.3.1. Diagnostics; 7.3.1.1. Infectious Diseases; 7.3.1.2. Cancer; 7.3.1.3. Others; 7.3.2. Therapeutics; 7.3.2.1. Gene Therapy; 7.3.2.2. Preventive Medicine; 7.3.2.3. Others; 7.3.3. Research & Development; 7.3.3.1. Cloning and Gene Editing; 7.3.3.2. Drug Discovery & Development; 7.3.3.3. Others; 7.4. Market Analysis, Insights and Forecast – By End User; 7.4.1. Pharmaceutical & Biotechnology Companies; 7.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs); 7.4.3. Others; 7.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region; 7.5.1. U.K.; 7.5.2. Germany; 7.5.3. France; 7.5.4. Italy; 7.5.5. Spain; 7.5.6. Scandinavia; 7.5.7. Rest of Europe
8. Asia Pacific DNA Synthesis Market Analysis, Insights and Forecast, 2019-2032: 8.1. Market Analysis, Insights and Forecast – By Product & Service; 8.1.1. Products; 8.1.1.1. Instruments; 8.1.1.2. Reagents & Consumables; 8.1.2. Services; 8.2. Market Analysis, Insights and Forecast – By Type; 8.2.1. Oligonucleotide Synthesis; 8.2.2. Gene Synthesis; 8.3. Market Analysis, Insights and Forecast – By Application; 8.3.1. Diagnostics; 8.3.1.1. Infectious Diseases; 8.3.1.2. Cancer; 8.3.1.3. Others; 8.3.2. Therapeutics; 8.3.2.1. Gene Therapy; 8.3.2.2. Preventive Medicine; 8.3.2.3. Others; 8.3.3. Research & Development; 8.3.3.1. Cloning and Gene Editing; 8.3.3.2. Drug Discovery & Development; 8.3.3.3. Others; 8.4. Market Analysis, Insights and Forecast – By End User; 8.4.1. Pharmaceutical & Biotechnology Companies; 8.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs); 8.4.3. Others; 8.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region; 8.5.1. Japan; 8.5.2. China; 8.5.3. India; 8.5.4. Australia; 8.5.5. Southeast Asia; 8.5.6. Rest of Asia Pacific
9. Latin America DNA Synthesis Market Analysis, Insights and Forecast, 2019-2032: 9.1. Market Analysis, Insights and Forecast – By Product & Service; 9.1.1. Products; 9.1.1.1. Instruments; 9.1.1.2. Reagents & Consumables; 9.1.2. Services; 9.2. Market Analysis, Insights and Forecast – By Type; 9.2.1. Oligonucleotide Synthesis; 9.2.2. Gene Synthesis; 9.3. Market Analysis, Insights and Forecast – By Application; 9.3.1. Diagnostics; 9.3.1.1. Infectious Diseases; 9.3.1.2. Cancer; 9.3.1.3. Others; 9.3.2. Therapeutics; 9.3.2.1. Gene Therapy; 9.3.2.2. Preventive Medicine; 9.3.2.3. Others; 9.3.3. Research & Development; 9.3.3.1. Cloning and Gene Editing; 9.3.3.2. Drug Discovery & Development; 9.3.3.3. Others; 9.4. Market Analysis, Insights and Forecast – By End User; 9.4.1. Pharmaceutical & Biotechnology Companies; 9.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs); 9.4.3. Others; 9.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region; 9.5.1. Brazil; 9.5.2. Mexico; 9.5.3. Rest of Latin America
10. Middle East & Africa DNA Synthesis Market Analysis, Insights and Forecast, 2019-2032: 10.1. Market Analysis, Insights and Forecast – By Product & Service; 10.1.1. Products; 10.1.1.1. Instruments; 10.1.1.2. Reagents & Consumables; 10.1.2. Services; 10.2. Market Analysis, Insights and Forecast – By Type; 10.2.1. Oligonucleotide Synthesis; 10.2.2. Gene Synthesis; 10.3. Market Analysis, Insights and Forecast – By Application; 10.3.1. Diagnostics; 10.3.1.1. Infectious Diseases; 10.3.1.2. Cancer; 10.3.1.3. Others; 10.3.2. Therapeutics; 10.3.2.1. Gene Therapy; 10.3.2.2. Preventive Medicine; 10.3.2.3. Others; 10.3.3. Research & Development; 10.3.3.1. Cloning and Gene Editing; 10.3.3.2. Drug Discovery & Development; 10.3.3.3. Others; 10.4. Market Analysis, Insights and Forecast – By End User; 10.4.1. Pharmaceutical & Biotechnology Companies; 10.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs); 10.4.3. Others; 10.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region; 10.5.1. GCC; 10.5.2. South Africa; 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis: 11.1. Global Market Share Analysis (2023); 11.2. Company Profiles; 11.2.1. Thermo Fisher Scientific Inc.; 11.2.1.1. Overview; 11.2.1.2. Products & services; 11.2.1.3. SWOT Analysis; 11.2.1.4. Recent Developments; 11.2.1.5. Strategies; 11.2.1.6. Financials (Based on Availability); 11.2.2. Integrated DNA Technologies, Inc. (Danaher); 11.2.2.1. Overview; 11.2.2.2. Products & services; 11.2.2.3. SWOT Analysis; 11.2.2.4. Recent Developments; 11.2.2.5. Strategies; 11.2.2.6. Financials (Based on Availability); 11.2.3. Eurofins Scientific; 11.2.3.1. Overview; 11.2.3.2. Products & services; 11.2.3.3. SWOT Analysis; 11.2.3.4. Recent Developments; 11.2.3.5. Strategies; 11.2.3.6. Financials (Based on Availability); 11.2.4. GenScript; 11.2.4.1. Overview; 11.2.4.2. Products & services; 11.2.4.3. SWOT Analysis; 11.2.4.4. Recent Developments; 11.2.4.5. Strategies; 11.2.4.6. Financials (Based on Availability); 11.2.5. Azenta, Inc.; 11.2.5.1. Overview; 11.2.5.2. Products & services; 11.2.5.3. SWOT Analysis; 11.2.5.4. Recent Developments; 11.2.5.5. Strategies; 11.2.5.6. Financials (Based on Availability); 11.2.6. LGC Limited; 11.2.6.1. Overview; 11.2.6.2. Products & services; 11.2.6.3. SWOT Analysis; 11.2.6.4. Recent Developments; 11.2.6.5. Strategies; 11.2.6.6. Financials (Based on Availability); 11.2.7. Biomatik; 11.2.7.1. Overview; 11.2.7.2. Products & services; 11.2.7.3. SWOT Analysis; 11.2.7.4. Recent Developments; 11.2.7.5. Strategies; 11.2.7.6. Financials (Based on Availability); 11.2.8. Telesis Bio Inc.; 11.2.8.1. Overview; 11.2.8.2. Products & services; 11.2.8.3. SWOT Analysis; 11.2.8.4. Recent Developments; 11.2.8.5. Strategies; 11.2.8.6. Financials (Based on Availability); 11.2.9. Twist Bioscience; 11.2.9.1. Overview; 11.2.9.2. Products & services; 11.2.9.3. SWOT Analysis; 11.2.9.4. Recent Developments; 11.2.9.5. Strategies; 11.2.9.6. Financials (Based on Availability); 11.2.10. Bioneer Corporation; 11.2.10.1. Overview; 11.2.10.2. Products & services; 11.2.10.3. SWOT Analysis; 11.2.10.4. Recent Developments; 11.2.10.5. Strategies; 11.2.10.6. Financials (Based on Availability)